GT Biopharma Inc.(GTBP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GTBP GT Biopharma Inc.

未开盘 11-18 16:00:00 EST

2.95

+0.03

+1.03%

盘后2.95

+0.000.00%

19:30 EST

最高3.05	最低2.73	成交量5.67万
今开2.90	昨收2.92	日振幅10.87%
总市值659.13万	流通市值491.26万	总股本223.43万
成交额16.25万	换手率3.40%	流通股本166.53万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GTBP","market":"US","secType":"STK","nameCN":"GT Biopharma Inc.","latestPrice":2.95,"timestamp":1731963600000,"preClose":2.92,"halted":0,"volume":56668,"hourTrading":{"tag":"盘后","latestPrice":2.95,"preClose":2.95,"latestTime":"19:30 EST","volume":3,"amount":8.76,"timestamp":1731976225322},"delay":0,"floatShares":1665292,"shares":2234328,"eps":-7.358045,"marketStatus":"未开盘","marketStatusCode":0,"change":0.03,"latestTime":"11-18 16:00:00 EST","open":2.9,"high":3.0458,"low":2.7284,"amount":162538.9713564,"amplitude":0.108699,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.358045,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732006800000},"adr":0,"adjPreClose":2.92,"postHourTrading":{"tag":"盘后","latestPrice":2.95,"preClose":2.95,"latestTime":"19:30 EST","volume":3,"amount":8.76,"timestamp":1731976225322},"volumeRatio":2.41239,"impliedVol":3.9697,"impliedVolPercentile":0.5263},"requestUrl":"/m/hq/s/GTBP/tweets","defaultTab":"tweets","newsList":[{"id":"2484672175","title":"Gt Biopharma, Inc.盘中异动 股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484672175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484672175?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:33","pubTimestamp":1731944029,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时33分，Gt Biopharma, Inc.股票出现波动，股价大幅下跌5.31%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118233349971a737f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118233349971a737f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2483880873","title":"Gt Biopharma, Inc.盘中异动 早盘股价大涨6.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483880873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483880873?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:19","pubTimestamp":1731511150,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日23时19分，Gt Biopharma, Inc.股票出现异动，股价急速上涨6.23%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113231910a2346f2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113231910a2346f2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2482784085","title":"Gt Biopharma, Inc.盘中异动 早盘急速下跌6.28%报3.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482784085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482784085?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:44","pubTimestamp":1731422692,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时44分，Gt Biopharma, Inc.股票出现波动，股价快速跳水6.28%。截至发稿，该股报3.25美元/股，成交量638股，换手率0.03%，振幅4.90%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112224452971a6053&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112224452971a6053&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2482589414","title":"Gt Biopharma, Inc.盘中异动 股价大涨6.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482589414","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482589414?lang=zh_cn&edition=full","pubTime":"2024-11-09 04:06","pubTimestamp":1731096360,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日04时06分，Gt Biopharma, Inc.股票出现波动，股价急速拉升6.45%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.11%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109040600971a5729&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109040600971a5729&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2481713182","title":"Gt Biopharma, Inc.盘中异动 快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481713182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481713182?lang=zh_cn&edition=full","pubTime":"2024-11-08 01:46","pubTimestamp":1731001594,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日01时46分，Gt Biopharma, Inc.股票出现波动，股价大幅拉升5.02%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108014634971a5298&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108014634971a5298&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2479303084","title":"Gt Biopharma, Inc.盘中异动 大幅下挫5.32%报2.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479303084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479303084?lang=zh_cn&edition=full","pubTime":"2024-10-31 23:26","pubTimestamp":1730388403,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日23时26分，Gt Biopharma, Inc.股票出现波动，股价快速跳水5.32%。截至发稿，该股报2.85美元/股，成交量1560股，换手率0.07%，振幅3.99%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为3.52%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103123264398e3fc37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103123264398e3fc37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2477352257","title":"Gt Biopharma, Inc.盘中异动 急速上涨5.17%报2.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477352257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477352257?lang=zh_cn&edition=full","pubTime":"2024-10-22 23:53","pubTimestamp":1729612413,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日23时53分，Gt Biopharma, Inc.股票出现异动，股价急速上涨5.17%。截至发稿，该股报2.55美元/股，成交量2.7561万股，换手率1.23%，振幅4.55%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102223533498e3dcee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102223533498e3dcee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2477863019","title":"Gt Biopharma, Inc.盘中异动 早盘快速上涨6.99%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477863019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477863019?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:42","pubTimestamp":1729518127,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时42分，Gt Biopharma, Inc.股票出现异动，股价急速拉升6.99%。截至发稿，该股报2.45美元/股，成交量4486股，换手率0.20%，振幅4.80%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021214207ab6bb7dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021214207ab6bb7dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2476480384","title":"Gt Biopharma, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476480384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476480384?lang=zh_cn&edition=full","pubTime":"2024-10-18 03:01","pubTimestamp":1729191717,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日03时01分，Gt Biopharma, Inc.股票出现波动，股价急速拉升5.00%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018030157ab6ae1f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018030157ab6ae1f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2473105230","title":"Gt Biopharma, Inc.盘中异动 急速上涨6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473105230","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473105230?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:33","pubTimestamp":1728308030,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时33分，Gt Biopharma, Inc.股票出现波动，股价大幅上涨6.06%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213350ab681a82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213350ab681a82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2472963193","title":"Gt Biopharma, Inc.盘中异动 早盘股价大跌7.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472963193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472963193?lang=zh_cn&edition=full","pubTime":"2024-10-04 22:43","pubTimestamp":1728053009,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日22时43分，Gt Biopharma, Inc.股票出现波动，股价快速下跌7.29%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004224329ab67bea4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004224329ab67bea4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2472544525","title":"Gt Biopharma, Inc.盘中异动 快速跳水6.31%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472544525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472544525?lang=zh_cn&edition=full","pubTime":"2024-10-02 21:31","pubTimestamp":1727875910,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日21时31分，Gt Biopharma, Inc.股票出现异动，股价大幅下挫6.31%。截至发稿，该股报2.08美元/股，成交量3745股，换手率0.17%，振幅0.90%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.87%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022131509f252ec0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022131509f252ec0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2472535361","title":"Gt Biopharma, Inc.盘中异动 急速拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472535361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472535361?lang=zh_cn&edition=full","pubTime":"2024-10-01 03:24","pubTimestamp":1727724255,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日03时24分，Gt Biopharma, Inc.股票出现波动，股价大幅拉升5.19%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410010324169719da77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410010324169719da77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2468532892","title":"Gt Biopharma, Inc.盘中异动 下午盘急速下挫5.33%报2.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468532892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468532892?lang=zh_cn&edition=full","pubTime":"2024-09-19 01:01","pubTimestamp":1726678908,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日01时01分，Gt Biopharma, Inc.股票出现异动，股价急速下跌5.33%。截至发稿，该股报2.13美元/股，成交量1725股，换手率0.08%，振幅2.17%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091901014998e37ed9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091901014998e37ed9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2467779784","title":"Gt Biopharma, Inc.盘中异动 急速下挫5.50%报2.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467779784","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467779784?lang=zh_cn&edition=full","pubTime":"2024-09-13 22:33","pubTimestamp":1726238014,"startTime":"0","endTime":"0","summary":"北京时间2024年09月13日22时33分，Gt Biopharma, Inc.股票出现波动，股价大幅下挫5.50%。截至发稿，该股报2.06美元/股，成交量522股，换手率0.02%，振幅0.00%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091322333598e378c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091322333598e378c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4539","IMRX","BK4139","BK4563"],"gpt_icon":0},{"id":"2459217359","title":"Gt Biopharma, Inc.盘中异动 急速下挫6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459217359","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459217359?lang=zh_cn&edition=full","pubTime":"2024-08-16 21:51","pubTimestamp":1723816270,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日21时51分，Gt Biopharma, Inc.股票出现波动，股价急速下跌6.33%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081621511097198f5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081621511097198f5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CING","BK4139","GTBP"],"gpt_icon":1},{"id":"2459177709","title":"Gt Biopharma, Inc.盘中异动 股价大跌9.04%报2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459177709","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459177709?lang=zh_cn&edition=full","pubTime":"2024-08-14 21:57","pubTimestamp":1723643874,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日21时57分，Gt Biopharma, Inc.股票出现异动，股价快速跳水9.04%。截至发稿，该股报2.19美元/股，成交量497股，换手率0.02%，振幅0.00%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814215755a1d4483d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814215755a1d4483d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2459909349","title":"Gt Biopharma, Inc.盘中异动 股价大涨7.76%报2.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459909349","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459909349?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:33","pubTimestamp":1723556028,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时33分，Gt Biopharma, Inc.股票出现异动，股价大幅拉升7.76%。截至发稿，该股报2.36美元/股，成交量799股，换手率0.04%，振幅0.46%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813213348af974227&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813213348af974227&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2458295985","title":"Gt Biopharma, Inc.盘中异动 早盘快速上涨15.89%报2.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458295985","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458295985?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:39","pubTimestamp":1723469981,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时39分，Gt Biopharma, Inc.股票出现波动，股价大幅上涨15.89%。截至发稿，该股报2.48美元/股，成交量570股，换手率0.03%，振幅0.00%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081221394296825bbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081221394296825bbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2457385346","title":"Gt Biopharma, Inc.盘中异动 急速拉升9.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457385346","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457385346?lang=zh_cn&edition=full","pubTime":"2024-08-08 23:41","pubTimestamp":1723131676,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日23时41分，Gt Biopharma, Inc.股票出现异动，股价急速上涨9.75%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为3.19%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808234116af96a1ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808234116af96a1ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.gtbiopharma.com","stockEarnings":[{"period":"1week","weight":-0.1492},{"period":"1month","weight":0.2882},{"period":"3month","weight":0.3785},{"period":"6month","weight":-0.4124},{"period":"1year","weight":-0.5824},{"period":"ytd","weight":-0.6144}],"compareEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":0.0061},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.1101},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.2374}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GT Biopharma, Inc.于1965年在加利福尼亚州注册成立。该公司是一个临床阶段的生物制药公司，专注于在使用他们的专利产品基础上开发和商业化新型免疫肿瘤产品。他们的TriKE和TetraKE平台开发出了专利性的疗法，旨在利用和增强患者自身NK细胞的癌症杀伤能力。他们正在使用TriKE和TetraKE平台，将免疫肿瘤产品推向市场，这些产品可以治疗一系列血液恶性肿瘤、肉瘤和实体肿瘤。他们还在使用这两个平台开发用于治疗传染病的治疗方法，例如用于治疗感染艾滋病毒的患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.011995},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.176161},{"month":3,"riseRate":0.5,"avgChangeRate":0.060093},{"month":4,"riseRate":0.333333,"avgChangeRate":0.014218},{"month":5,"riseRate":0.571429,"avgChangeRate":0.084634},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.035324},{"month":7,"riseRate":0.285714,"avgChangeRate":0.000588},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.081681},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.134536},{"month":10,"riseRate":0.714286,"avgChangeRate":0.052025},{"month":11,"riseRate":0.142857,"avgChangeRate":-0.181142},{"month":12,"riseRate":0.333333,"avgChangeRate":0.035421}],"exchange":"NASDAQ","name":"GT Biopharma Inc.","nameEN":"GT Biopharma Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GT Biopharma Inc.(GTBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GT Biopharma Inc.(GTBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GT Biopharma Inc.,GTBP,GT Biopharma Inc.股票,GT Biopharma Inc.股票老虎,GT Biopharma Inc.股票老虎国际,GT Biopharma Inc.行情,GT Biopharma Inc.股票行情,GT Biopharma Inc.股价,GT Biopharma Inc.股市,GT Biopharma Inc.股票价格,GT Biopharma Inc.股票交易,GT Biopharma Inc.股票购买,GT Biopharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GT Biopharma Inc.(GTBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GT Biopharma Inc.(GTBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}